Acura Pharmaceuticals Probability of Future OTC Stock Price Finishing Over 0.05
| ACURDelisted Stock | USD 0.05 0.00 0.00% |
Acura |
Acura Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Acura Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Acura Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Acura Pharmaceuticals is not yet fully synchronised with the market data | |
| Acura Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Acura Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company currently holds 105 K in liabilities with Debt to Equity (D/E) ratio of 2.4, implying the company greatly relies on financing operations through barrowing. Acura Pharmaceuticals has a current ratio of 0.84, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Acura Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Acura Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Acura Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Acura to invest in growth at high rates of return. When we think about Acura Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 3.57 M. Net Loss for the year was (1.21 M) with profit before overhead, payroll, taxes, and interest of 1.79 M. | |
| Acura Pharmaceuticals currently holds about 89 K in cash with (719 K) of positive cash flow from operations. | |
| Roughly 19.0% of Acura Pharmaceuticals shares are held by company insiders |
Acura Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Acura OTC Stock often depends not only on the future outlook of the current and potential Acura Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acura Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.6 M |
Acura Pharmaceuticals Technical Analysis
Acura Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Acura OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Acura Pharmaceuticals. In general, you should focus on analyzing Acura OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Acura Pharmaceuticals Predictive Forecast Models
Acura Pharmaceuticals' time-series forecasting models is one of many Acura Pharmaceuticals' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Acura Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Acura Pharmaceuticals
Checking the ongoing alerts about Acura Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Acura Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Acura Pharmaceuticals is not yet fully synchronised with the market data | |
| Acura Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Acura Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company currently holds 105 K in liabilities with Debt to Equity (D/E) ratio of 2.4, implying the company greatly relies on financing operations through barrowing. Acura Pharmaceuticals has a current ratio of 0.84, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Acura Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Acura Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Acura Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Acura to invest in growth at high rates of return. When we think about Acura Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 3.57 M. Net Loss for the year was (1.21 M) with profit before overhead, payroll, taxes, and interest of 1.79 M. | |
| Acura Pharmaceuticals currently holds about 89 K in cash with (719 K) of positive cash flow from operations. | |
| Roughly 19.0% of Acura Pharmaceuticals shares are held by company insiders |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Acura OTC Stock
If you are still planning to invest in Acura Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acura Pharmaceuticals' history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Transaction History View history of all your transactions and understand their impact on performance |